Un ECG de 1925 : diagnostic rétrospectif cardiologique chez Georges Clemenceau [0.03%]
一份1925年的ECG——对乔治·克里孟梭的心脏回顾性诊断
Philippe Charlier,Joël Rivagorda,Lise Lentignac
Philippe Charlier
Corrigendum to ‘Safety of exercise training for cardiac patients : results of a French multicenter COCARE study (COmplications in CArdiac REhabilitation)’[Annales de cardiologie et d’angéiologie 74 (2025) 101940] [0.03%]
“心脏患者运动训练的安全性：法国多中心COCARE研究（心脏康复并发症）结果”一文的勘误通知(Corrected publication date: January 2025)
Bruno Pavy,Marie-Christine Iliou,Mohamed Ghannem et al.
Bruno Pavy et al.
Impact on slow-flow/no-reflow of intravascular ultrasound-guided primary percutaneous coronary intervention in ST-elevation myocardial infarction [0.03%]
血管内超声引导下的急性ST段抬高型心肌梗死直接皮冠脉介入治疗对慢复流/无复流的影响
Etienne Grenier,Sarah Balichard,Gaël Bouchou et al.
Etienne Grenier et al.
Background: Intravascular imaging (IVI) using intravascular ultrasound (IVUS) or optical coherence tomography is now strongly recommended to guide percutaneous coronary intervention (PCI), as studies have shown reduced ra...
[MINOCA revealing an anomalous origin of right coronary artery and a pheochromocytoma : A case report with literature review] [0.03%]
右冠状动脉异常起源于肺动脉并伴有嗜铬细胞瘤的MINOCA病例报告及文献回顾
A Owona,C Ebeni,B Y Mengue et al.
A Owona et al.
Pheochromocytoma is a rare secretory neuroendocrine tumor of the adrenal medulla, which usually presents with Ménard's triad or high blood pressure. Its diagnosis is based on elevated adrenaline and noradrenaline levels. Cross-sectional im...
[Workshop on connected devices and maintenance of physical activity at home : A preliminary descriptive study in cardiac patients] [0.03%]
基于连接设备和居家保持身体活动的心脏病患者维修研讨会：一项初步描述性研究
Julie Capart,Florent Krim,Aurélien Dassonneville et al.
Julie Capart et al.
There is a link between physical activity level and survival of cardiac patient. Less than 50 % of patients would remain physically active two months after a phase II cardiac rehabilitation. ...
[Programme d'exercice supervisé de réadaptation cardiovasculaire pour l'artériopathie oblitérante des membres inférieurs : effet sur l'amélioration de la marche, des paramètres hémodynamiques, de l'anxiété, de la dépression et de la qualité de vie au Cameroun] [0.03%]
[下肢动脉闭塞性疾病心脏康复监督锻炼计划：对喀麦隆患者的行走能力、血液动力学参数、焦虑、抑郁和生活质量改善的影响]
Valérie Ndobo,Augustine Telouwe Ndava,Hermann Tsague et al.
Valérie Ndobo et al.
Background: Lower-limb peripheral arterial disease (PAD) is underdiagnosed despite its high prevalence among patients with cardiovascular risk factors. Given the well-documented benefits of physical activity on physical a...
[Profile and management of non-ST-segment elevation acute coronary syndromes hospitalized in Dakar] [0.03%]
[达喀尔非ST段抬高型急性冠脉综合征住院患者的特征与管理]
Papa Guirane Ndiaye,Aliou Alassane Ngaide,Abdoulgabar Souleiman et al.
Papa Guirane Ndiaye et al.
Non-ST-segment elevation acute coronary syndrome (NSTE-ACS) is the most common form of acute coronary syndrome. Its diagnosis and management have always been subjects of controversy, complicating its treatment, particularly in our setting. ...
Un signe de Frank (Diagonal Earlobe Crease) chez Georges Clemenceau (1929) [0.03%]
乔治·克列孟梭（1929）的迪亚哥耳垂线（Frank征）符号
P Charlier,L Lentignac,S Lhortolary
P Charlier
[Temps passé dans l'intervalle thérapeutique dans la maladie veineuse thrombo-embolique : intérêt dans la prévention des complications] [0.03%]
血栓性疾病治疗窗内时间与并发症预防的关系
Imène Rachdi,Mariem Ben Brahim,Mehdi Somai et al.
Imène Rachdi et al.
Background: Vitamin K antagonists (VKAs) are the most commonly prescribed drug for the treatment of venous thromboembolism (VTE). Our study's aim was to evaluate the role of Time in Therapeutic Range (TTR) in preventing t...
[Complications thromboemboliques après un traitement par rituximab chez une patiente atteinte de pemphigoïde bulleuse : un cas clinique] [0.03%]
[利妥昔单抗治疗后出现血栓栓塞并发症的天疱疮患者病例报告]
Nouhaila Wakil,Lamia Tlohi,Meryem Haboub et al.
Nouhaila Wakil et al.
Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third leading cause of cardiovascular mortality worldwide, following stroke and myocardial infarction. Rituximab, a monoclonal antibod...